Study Stopped
transferred to different institution
PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2018
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2020
CompletedFebruary 12, 2020
February 1, 2020
1.4 years
July 31, 2018
February 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion Patients with Hospital Reutilization
proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge
30 days post hospital discharge
Study Arms (2)
PHARMD-TOC i
EXPERIMENTALPharmD Follow-Up Post Discharge
USUAL CARE
ACTIVE COMPARATORUsual Post Discharge Procedures
Interventions
patients participating in a community pharmacy-based Transitions of Care Program (PHARMD-TOC)
Eligibility Criteria
You may qualify if:
- \- Admission LACE Score: in moderate range (5 to 9) And
- Taking high risk medication(s): anticoagulants, insulin, oral antiplatelet agents, oral hypoglycemic agents, opioid analgesics, digoxin Or Taking at least 5 medications AND have one of following: CHF, COPD, Asthma, Pneumonia, Diabetes, ESRD, Schizophrenia, Bi-Polar, Dizziness, History of Falls
- And
- Medical or Surgical Unit patients
- Age \> 18 years
- Being discharged to home (with or without Home Health services)
- English and/or Spanish speaking
- Will have access to a telephone post-discharge
- Ability to give consent
- Patient admitted to hospital through the emergency department, as a direct admission or as a transfer, or as an elective surgery patient
You may not qualify if:
- \- Patients with observation status
- Caremore Health Plan patients (Caremore has a separate post-discharge program)
- Patients discharged and followed up by the PIH Coumadin Clinic
- Patients discharged to Residential MD House Calls program
- Patients discharged to Skilled Nursing Facility
- Anyone with planned readmissions
- Obstetrics patients
- Hospice patients
- Oncology patients
- Anyone who does not meet provisions of protocol
- Anyone unwilling or unable to give consent for study procedures and data access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Clinical Pharmacy
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 6, 2018
Study Start
October 1, 2018
Primary Completion
February 10, 2020
Study Completion
February 10, 2020
Last Updated
February 12, 2020
Record last verified: 2020-02